DCE-MRI model selection for investigating disruption of microvascular function in livers with metastatic disease

Geoffrey Parker, Anita Banerji, Josephine H. Naish, Yvonne Watson, Gordon C. Jayson, Giovanni A. Buonaccorsi, Geoffrey J M Parker

    Research output: Contribution to journalArticlepeer-review


    Purpose: To evaluate the Akaike information criterion (AIC) model selection technique as a method for detecting differences in microvascular characteristics between tumorous and non-tumor liver tissue. Materials and Methods: The AIC was applied to six patient datasets with liver metastases to determine, on a per voxel basis, which of two physiologically plausible candidate models gave a more appropriate description of the data. The dual-input single-compartment Materne model, extended to incorporate a novel portal input function estimation method, was chosen to represent liver tissue and the single-input dual-compartment extended Kety model was used for tumor. Results: Median AIC probabilities when comparing tumor versus liver and tumor versus tumor-margins were significantly different (P ≤ 0.01) in five of the six patient datasets. Comparisons between tumor margins and liver regions were significantly different in four datasets. Median AIC probabilities selected for the extended Kety model in all tumor regions, with the Materne model being progressively more probable through tumor margins into liver. Conclusion: We present a viable method for assessing the spatially varying microvascular characteristics of tumor-bearing livers, with possible applications in lesion detection, assessment of tumor invasion, and measurement of drug efficacy. © 2011 Wiley Periodicals, Inc.
    Original languageEnglish
    Pages (from-to)196-203
    Number of pages7
    JournalJournal of Magnetic Resonance Imaging
    Issue number1
    Publication statusPublished - Jan 2012


    • cancer
    • DCE-MRI
    • liver


    Dive into the research topics of 'DCE-MRI model selection for investigating disruption of microvascular function in livers with metastatic disease'. Together they form a unique fingerprint.

    Cite this